Product Name | YTHDF2 Antibody, Biotin conjugated |
---|---|
Description | Rabbit polyclonal antibody against YTHDF2 conjugated to Biotin. |
Synonyms | 9430020E02Rik antibody; CAHL antibody; CLL associated antigen KW 14 antibody; CLL-associated antigen KW-14 antibody; HGRG8 antibody; High glucose regulated protein 8 antibody; High-glucose-regulated protein 8 antibody; NY REN 2 antibody; Renal carcinoma antigen NY REN 2 antibody; Renal carcinoma antigen NY-REN-2 antibody; YTH domain family 2 antibody; YTH domain family member 2 antibody; YTH domain family protein 2 antibody; YTH N6 methyladenosine RNA binding protein 2 antibody; YTHD2_HUMAN antibody; YTHDF 2 antibody; YTHDF2 antibody |
Host | Rabbit |
Clonality | Polyclonal |
Conjugate | Biotin |
Immunogen | Recombinant human YTH domain-containing family protein 2 protein (201-500AA) |
Isotype | IgG |
Target | YTHDF2 |
Reactivity | Human |
Applications | ELISA |
Form | Liquid |
Diluent Buffer | Preservative: 0.03% Proclin 300Constituents: 50% Glycerol, 0.01M PBS, PH 7.4 |
Uniprot | Q9Y5A9 |
Storage | Upon receipt, store at -20°C or -80°C. Avoid repeated freeze. |
Background | Specifically recognizes and binds N6-methyladenosine (m6A)-containing RNAs, and regulates mRNA stability (PubMed:24284625, PubMed:26046440). M6A is a modification present at internal sites of mRNAs and some non-coding RNAs and plays a role in the efficiency of mRNA splicing, processing and stability (PubMed:22575960, PubMed:24284625, PubMed:25412658, PubMed:25412661). Acts as a regulator of mRNA stability: binding to m6A-containing mRNAs results in the localization to mRNA decay sites, such as processing bodies (P-bodies), leading to mRNA degradation (PubMed:24284625, PubMed:26046440). |
Supplier | Cusabio |
All Research Products are sold for laboratory RESEARCH USE ONLY and ARE NOT TO BE USED FOR HUMAN OR ANIMAL THERAPEUTIC OR DIAGNOSTIC APPLICATIONS. The information presented is believed to be accurate; however, said information and products are offered without warranty or guarantee since the ultimate conditions of use and the variability of the materials treated are beyond our control. Nothing disclosed herein is to be construed as a recommendation to use our products in violation of any patents. ARP American Research Products, Inc. does not submit its products for regulatory review by any government body or other organization, and we do not validate them for clinical, therapeutic or diagnostic use, or for safety and effectiveness. You are solely responsible for making sure that the way you use the products complies with applicable laws, regulations and governmental policies and for obtaining all necessary approvals, intellectual property rights, licenses and permissions that you may need related to your use. Under no circumstances shall ARP American Research Products, Inc. be liable for damages, whether consequential, compensatory, incidental or special, strict liability or negligence, breach of warranty or any other theory arising out of the use of the products available from ARP American Research Products, Inc. Nothing contained herein warrants that the use of the products will not infringe on the claims of any patents covering the product itself or the use thereof in combination with other products or in the operation of any process. ARP American Research Products, Inc. disclaims any and all representations or warranties of any kind whatsoever, express or implied, including without limitation any implied warranties of merchantability or fitness for a particular purpose, of non-infringement, or regarding results obtained through the use of any product, whether arising from a statute or otherwise in law or from a course of performance, dealing or usage of trade.